BACKGROUND: Demand for surgery to treat osteoarthritis (OA) of the hip, knee and spine has risen dramatically. Whereas total hip (THA) and total knee arthroplasty (TKA) have been widely accepted as cost-effective, spine surgeries (decompression, decompression with fusion) to treat degenerative conditions remain underfunded compared with other surgeries. METHODS: An incremental cost-utility analysis comparing decompression and decompression with fusion to THA and TKA, from the perspective of the provincial health insurance system, was based on an observational matched-cohort study of prospectively collected outcomes and retrospectively collected costs. Patient outcomes were measured using short-form (SF)-36 surveys over a 2-year follow-up period. Utility was modelled over the lifetime, and quality-adjusted life years (QALYs) were determined. We calculated the incremental cost per QALY gained by estimating mean incremental lifetime costs and QALYs of surgery compared with medical management of each diagnosis group after discounting costs and QALYs at 3%. Sensitivity analyses were also conducted. RESULTS: The lifetime incremental cost:utility ratios (ICURs) discounted at 3% were $5321 per QALY for THA, $11,275 per QALY for TKA, $2307 per QALY for spinal decompression and $7153 per QALY for spinal decompression with fusion. The sensitivity analyses did not alter the ranking of the lifetime ICURs. CONCLUSION: In appropriately selected patients with leg-dominant symptoms secondary to focal lumbar spinal stenosis who have failed medical management, the lifetime ICUR for surgical treatment of.
BACKGROUND: Demand for surgery to treat osteoarthritis (OA) of the hip, knee and spine has risen dramatically. Whereas total hip (THA) and total knee arthroplasty (TKA) have been widely accepted as cost-effective, spine surgeries (decompression, decompression with fusion) to treat degenerative conditions remain underfunded compared with other surgeries. METHODS: An incremental cost-utility analysis comparing decompression and decompression with fusion to THA and TKA, from the perspective of the provincial health insurance system, was based on an observational matched-cohort study of prospectively collected outcomes and retrospectively collected costs. Patient outcomes were measured using short-form (SF)-36 surveys over a 2-year follow-up period. Utility was modelled over the lifetime, and quality-adjusted life years (QALYs) were determined. We calculated the incremental cost per QALY gained by estimating mean incremental lifetime costs and QALYs of surgery compared with medical management of each diagnosis group after discounting costs and QALYs at 3%. Sensitivity analyses were also conducted. RESULTS: The lifetime incremental cost:utility ratios (ICURs) discounted at 3% were $5321 per QALY for THA, $11,275 per QALY for TKA, $2307 per QALY for spinal decompression and $7153 per QALY for spinal decompression with fusion. The sensitivity analyses did not alter the ranking of the lifetime ICURs. CONCLUSION: In appropriately selected patients with leg-dominant symptoms secondary to focal lumbar spinal stenosis who have failed medical management, the lifetime ICUR for surgical treatment of.
Authors: Jeffrey L Mahon; Robert B Bourne; Cecil H Rorabeck; David H Feeny; Larry Stitt; Susan Webster-Bogaert Journal: CMAJ Date: 2002-11-12 Impact factor: 8.262
Authors: D L Reynolds; L W Chambers; E M Badley; K J Bennett; C H Goldsmith; E Jamieson; G W Torrance; P Tugwell Journal: J Rheumatol Date: 1992-07 Impact factor: 4.666
Authors: Gillian A Hawker; Elizabeth M Badley; Ruth Croxford; Peter C Coyte; Richard H Glazier; Jun Guan; Bart J Harvey; J I Williams; James G Wright Journal: Med Care Date: 2009-07 Impact factor: 2.983
Authors: Joseph F Konopka; Andreas H Gomoll; Thomas S Thornhill; Jeffrey N Katz; Elena Losina Journal: J Bone Joint Surg Am Date: 2015-05-20 Impact factor: 5.284
Authors: Anne F Mannion; Franco M Impellizzeri; Michael Leunig; Dezsö Jeszenszy; Hans-Jürgen Becker; Daniel Haschtmann; Stefan Preiss; Tamas F Fekete Journal: Eur Spine J Date: 2018-02-19 Impact factor: 3.134
Authors: J A D van der Woude; S C Nair; R J H Custers; J M van Laar; N O Kuchuck; F P J G Lafeber; P M J Welsing Journal: PLoS One Date: 2016-05-12 Impact factor: 3.240
Authors: Lidia García-Pérez; Vanesa Ramos-García; Pedro Serrano-Aguilar; José Luis Pais-Brito; María Aciego de Mendoza; Jesús Martín-Fernández; Roberto García-Maroto; Juan Carlos Arenaza; Amaia Bilbao Journal: Health Qual Life Outcomes Date: 2019-10-30 Impact factor: 3.186